45°
He will serve the Praxair Cancer Center at Danbury Hospital, the Diebold Family Cancer Center at New Milford Hospital and the Whittingham Cancer Center at Norwalk Hospital.
Over the next few years, Rutherford will lead the expansion of WCHN cancer services.
He will focus on all aspects of cancer treatment including prevention, high-risk screening, research, individualized treatment and survivorship.
Rutherford believes that the disease-site specific programs comprised of teams led by surgeons, medical oncologists and radiation oncologists will develop a unified state-of-the-art treatment plan for all patients at the WCHN Cancer Centers.
"We are thrilled to have Dr. Rutherford join the WCHN family and lead our expert cancer team," said Dr. John Murphy, president and chief executive officer. "Tom has an outstanding reputation for his clinical and research experience, and compassionate approach to caring for patients. His vision and leadership will enhance the great care provided by an excellent team in place today and guide us as we transform cancer care for our community."
Rutherford is a board-certified gynecological oncologist, who has authored more than 100 scientific journal articles and worked to isolate the stem cell associated with ovarian cancer.
Previously, he served as professor of gynecologic oncology and director of the Gynecologic Oncology Fellowship at Yale University School of Medicine in New Haven.
He earned his bachelor's degree from Roanoke College and his doctoral and medical degrees from the Medical College of Ohio at Toledo.
Rutherford will be available for consultation at Norwalk Hospital, Danbury Hospital and St, Vincent's Hospital in Bridgeport. For appointments, call 203-299-0290.
For more information about WCHN, visit its website.
Click here to follow Daily Voice Norwalk and receive free news updates.
